Importantly, we also found that CD31 immunoreactivity was reduced in xenograft tumors from ATRA-treated mice, indicating a mechanism of action for ATRA in tumor angiogenesis in vivo (Fig 5E). This evidence concerns the gene PECAM1 and neoplasm.